Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mammaglobin A (SCGB2A2) is a small, secreted protein highly specific to mammary tissue. It is frequently overexpressed in breast carcinomas and serves as a diagnostic marker for detecting circulating tumor cells or micrometastases. While its exact physiological role is incompletely understood, it is believed to play roles in cell signaling, immune response, chemotaxis, and steroid hormone transport. Recent studies suggest its potential as a therapeutic target for antibody-mediated drug delivery.
Antibody-mediated drug delivery (potential)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mammaglobin A (MGB1).